[Intracavitary use of highly radioactive foci in the treatment of uterine carcinoma (author's transl)].
The report relates to the survival period of 24--44 months after the end of treatment and has a preliminary character. In 213 patients the radiological treatment was applied, either alone or combined with surgery. A total of 174 patients (81.6%) are alive, without any sign of malignity. In the observed period 29 patients sorders. In addition to protecting medied of carcinoma or intercurrent didical staff from radiation, the method described has also other advantages: 1. Radiation is of short duration, it last only a few minutes, 2. Subjective complaints in the course and after treatment are negligible, 3. Owing to its possible non-hospital application, patients are free of "cancer psychosis" which developes in respective hospitals, 4. Complications in the course and after treatment are fewer than with classical radiation methods, 5. Disappearance of malignant cells from the vaginal swab and regression of the tumour are twice as fast as with classical methods. 6. In advanced stages of the disease better results are obtained.
D001918:Brachytherapy / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery
Intrakavitarna primena visokoradioaktivnih fokusa u tretmanu karcinoma uterusa.